Thiruvananthapuram, Oct 25 (PTI) The monoclonal antibodies which are the only treatment against Nipah infection will be developed indigenously to combat the deadly virus, Kerala Health Minister Veena George said on Wednesday.

George revealed that a decision had been taken by two national and a Kerala government institute to develop monoclonal antibodies.

Also Read | Madhya Pradesh Assembly Elections 2023: Amit Shah on Three Day Visit to State As Polls Enter Last Lap.

The Kerala government's Institute of Advanced Virology, the Rajiv Gandhi Centre for Biotechnology (RGCB) and the National Institute of Virology in Pune would be involved in the effort, she said.

The minister said it was being considered to develop the antibodies using the cells of patients who recovered from the virus which infected six persons, of whom two died, in Kozhikode district of the state last month.

Also Read | Assam Witnessed Nearly 1,400 Cases of Murder, Rape and Dacoity in January-August 2023, Says CM Himanta Biswa Sarma.

The minister said the monoclonal antibodies were presently being imported from Australia where they are made according to the Nipah variant present there.

"We need to manufacture it indigenously for the variant seen here," she said.

The virus strain seen in Kerala was the Bangladesh variant, which has a high mortality rate of around 70-90 per cent.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)